NexgenRx Inc. (TSXV:NXG)
Canada · Delayed Price · Currency is CAD 0.6500
+0.0300 (4.84%)
Oct 19, 2026, 3:04 PM EST
NexgenRx Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 46 | 28 | 20 | 16 | 19 | 28 | |
Market Cap Growth | 62.50% | 45.45% | 26.04% | -16.75% | -33.75% | 67.66% |
Enterprise Value | 45 | 28 | 20 | 16 | 19 | 30 |
Last Close Price | 0.62 | 0.39 | 0.26 | 0.19 | 0.23 | 0.34 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.01 | 26.87 | 46.95 | - | - | 7.00 |
PS Ratio | 2.28 | 1.59 | 1.19 | 1.12 | 1.46 | 2.38 |
PB Ratio | 4.70 | 3.73 | 2.57 | 2.01 | 2.11 | 2.90 |
P/TBV Ratio | 7.97 | 8.14 | 8.13 | 9.26 | 10.01 | 16.49 |
P/FCF Ratio | 14.48 | 6.08 | 18.37 | 12.93 | 27.52 | 7.61 |
P/OCF Ratio | 13.55 | 5.72 | 17.00 | 12.15 | 17.48 | 7.36 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.19 | 1.56 | 1.20 | 1.13 | 1.48 | 2.51 |
EV/EBITDA Ratio | 12.43 | 11.37 | 14.11 | 229.95 | 12.31 | 8.95 |
EV/EBIT Ratio | 11.74 | 12.53 | 16.56 | - | 65.55 | 13.49 |
EV/FCF Ratio | 13.94 | 5.98 | 18.63 | 13.02 | 27.84 | 8.02 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.05 | 0.07 | 0.06 | 0.05 | 0.04 |
Debt / EBITDA Ratio | 0.08 | 0.14 | 0.36 | 3.62 | 0.26 | 0.11 |
Debt / FCF Ratio | 0.09 | 0.08 | 0.50 | 0.39 | 0.64 | 0.11 |
Net Debt / Equity Ratio | -0.35 | -0.58 | -0.15 | -0.18 | -0.15 | -0.20 |
Net Debt / EBITDA Ratio | -0.99 | -1.79 | -0.83 | -20.82 | -0.87 | -0.58 |
Net Debt / FCF Ratio | -1.08 | -0.94 | -1.10 | -1.18 | -1.97 | -0.52 |
Asset Turnover | 0.47 | 0.54 | 0.54 | 0.50 | 0.46 | 0.43 |
Quick Ratio | 0.19 | 0.19 | 0.11 | 0.12 | 0.13 | 0.14 |
Current Ratio | 1.15 | 1.13 | 1.10 | 1.06 | 1.09 | 1.07 |
Return on Equity (ROE) | 30.10% | 16.92% | 8.01% | -4.01% | -0.24% | 52.75% |
Return on Assets (ROA) | 5.54% | 4.16% | 2.47% | -0.32% | 0.65% | 5.03% |
Return on Invested Capital (ROIC) | 55.06% | 30.80% | 11.24% | -2.08% | -0.63% | 31.50% |
Return on Capital Employed (ROCE) | 37.50% | 28.20% | 14.90% | -1.80% | 3.10% | 22.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.37% | 4.53% | 3.14% | -2.14% | -0.12% | 14.28% |
FCF Yield | 6.91% | 16.45% | 5.44% | 7.74% | 3.63% | 13.14% |
Dividend Yield | 2.31% | 3.75% | 3.64% | 4.54% | 3.77% | - |
Payout Ratio | 50.59% | 100.62% | 147.78% | - | - | 3.25% |
Buyback Yield / Dilution | 3.03% | -0.68% | -8.51% | -0.28% | 6.01% | -0.88% |
Total Shareholder Return | 5.45% | 3.07% | -4.87% | 4.27% | 9.79% | -0.88% |